 |
 |
 |
For Market’s Latest Update Join Us on Telegram
 |
Objective of the Issue
The Company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use.
- Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.
- Prepayment or repayment of all or a portion of certain loans availed by the Company.
- General Corporate Purposes.
IPO Details, Price, Market Lot
| Onyx Biotec SME IPO Details | |
| IPO Open Date | 13 November 2024 |
| IPO Close Date | 18 November 2024 |
| IPO Issue Size | 4,810,000 shares (aggregating up to ₹29.34 Cr) |
| Fresh Issue | 4,810,000 shares (aggregating up to ₹29.34 Cr) |
| Offer for Sale | NIL |
| Retail Portion | Not less than 35% of the offer |
| NII Portion | Not less than 15% of the offer |
| QIB Portion | Not more than 50% of the offer |
| Listing At | NSE SME |
| Onyx Biotec SME IPO Price | |
| Face Value | ₹10 Per Share |
| IPO Price Band | ₹58 to ₹61 Per Share |
| Employee Discount | — |
| IPO Issue Type | Book Built Issue |
| Onyx Biotec SME IPO Market Lot For Retail Investor | |
| No. of Shares Per Lot | 2000 Shares |
| Minimum Lot Size | 1 Lot (2000 Shares) |
| Minimum Amount (Cut-off price) | ₹1,22,000 |
| Maximum Lot Size | 1 Lot (2000 Shares) |
| Maximum Amount (Cut-off price) | ₹1,22,000 |
| Onyx Biotec SME IPO Market Lot For HNI | |
| No. of Shares Per Lot | 2000 Shares |
| Minimum Lot Size | 2 Lots (4000 Shares) |
| Minimum Amount (Cut-off price) | ₹2,44,000 |
IPO Date, Listing Date, Allotment Date
| Onyx Biotec SME IPO Time Table (Tentative) | |
| IPO Open Date | 13 November 2024 |
| IPO Close Date | 18 November 2024 |
| Basis of Allotment Date | 19 November 2024 |
| Initiation of Refunds | 20 November 2024 |
| Credit of Share to Demat Account | 20 November 2024 |
| IPO Listing Date | 21 November 2024 |
Financial Report
| Period Ended | Assets (₹ in Lakh) |
Revenue (₹ in Lakh) |
P A T (₹ in Lakh) |
Net Worth (₹ in Lakh) |
Borrowings (₹ in Lakh) |
| 31 May 2024 | 7,476.57 | 1,054.11 | 130.77 | 2,618.64 | 3,156.14 |
| 31 March 2024 | 7,413.58 | 5,387.43 | 303.16 | 2,487.87 | 3,078.04 |
| 31 March 2023 | 5,872.36 | 3,961.65 | 184.46 | 1,820.16 | 2,922.83 |
| 31 March 2022 | 3,683.84 | 4,498.09 | 335.29 | 1,637.59 | 1,224.39 |
| Period Ended | 31 May 2024 | 31 March 2024 | 31 March 2023 | 31 March 2022 |
| Assets | 7,476.57 | 7,413.58 | 5,872.36 | 3,683.84 |
| Revenue | 1,054.11 | 5,387.43 | 3,961.65 | 4,498.09 |
| P A T | 130.77 | 303.16 | 184.46 | 335.29 |
| Net Worth | 2,618.64 | 2,487.87 | 1,820.16 | 1,637.59 |
| Borrowings | 3,156.14 | 3,078.04 | 2,922.83 | 1,224.39 |
| Amount in ₹ Lakh | ||||
Company Promotor & Promotor’s Holding
| Pre Issue Promotor Holding | 88.60% |
| Post Issue Promotor Holding |
Company Address
IPO Registrar, Lead Manager, Prospectus
| IPO Prospectus |
| Onyx Biotec SME IPO Registrar |
| Mas Services Limited |
| Onyx Biotec SME IPO Lead Manager |
| Horizon Management Private Limited |